Healthcare Huddle
Huddle+ Membership
Premium Newsletters
Partnerships
Login
Subscribe
Healthcare Huddle
Topics
Drug Supply Chain
Drug Supply Chain
Exploring drug pricing, PBMs, and pharmacy roles in medication access.
Huddle Trends
Medicine
Inefficiency Insights
Public Health
Policy
Drug Supply Chain
Sponsored Deep Dives
Insurance
Digital Health
Business
Feb 04, 2024
A Comprehensive Analysis of Mark Cuban's Cost Plus Drugs Company
Huddle+ | Huddle #Trends
Jared Dashevsky, MD
Jan 28, 2024
The Rise of Humira Biosimilars and the Battle for Market Share
Jared Dashevsky, MD
Nov 04, 2023
Streaming a Cure: How Subscription Models May Improve Healthcare Access
Jared Dashevsky, MD
Sep 02, 2023
CMS Takes the Reins: The Big Shake-Up in Medicare Drug Pricing
Jared Dashevsky, MD
Aug 26, 2023
The Unbundling: Is Blue Shield’s Big Move a PBM Game-Changer?
Jared Dashevsky, MD
Jul 22, 2023
The Rise of Humira Biosimilars and the Adoption Challenge
Jared Dashevsky, MD
Jul 08, 2023
Cost Plus Drugs: Key Updates from H1 ‘23
Jared Dashevsky, MD
Jul 01, 2023
Medicare vs. Pharma: The Legal Fallout of the Inflation Reduction Act
Jared Dashevsky, MD
Feb 25, 2023
Premium
Prescription Predicament: How Three New Models are Tackling Drug Prices
Huddle+ | Huddle #Trends
Jared Dashevsky, MD
Feb 04, 2023
Looking Back, Looking Ahead: Mark Cuban’s Cost Plus Drugs Company
Jared Dashevsky, MD
Jan 29, 2023
The End of the Billion-Dollar Drug
Jared Dashevsky, MD
Oct 09, 2022
Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation
Jared Dashevsky, MD
Load More